Robert Lyons

Background

About Robert Lyons

Synthesis Technologies has been formed to align and channel technologies into targeted, viable projects. We have included experts in various fields of interest and plan to offer consultation, contract services/support, as well as strategic partner building and alliance creation in chosen channels. In select cases, we will offer specific technology that has been identified as unique and high impact for license - and offer ourselves as a conduit for this option to third parties in order to create synergy, leverage and ultimately the ideal synthesis of elements for success. Synthesis Technology Consortium Synthesis is working with a highly regarded and expert group focused on new and challenging technologies in the clean energy domain, as well as for technologies that are, or promise to be, of high impact in the bioscience arena. We are presently establishing channels to begin that process with individuals prominent in the NASA/JPL technology sector - who will identify and help spawn these efforts from a library of unique applications that reside at NASA and related institutions and will apply them to new and high impact use in the commercial sectors of energy and bioscience. The program will channel and support these technologies to users and strategic partners in order to create new applications in innovative ways in the areas defined. Transmorgifiers, Inc. JPL data scientists created parser for data languages and compiler creation. Moving to market in 2024. Patents in place Roc8Sci, Inc. JPL scientist developed IR based detection technology for bio metrics from stand off locations. Patents in place PBD Biotech PBD (a UK firm) has introduced a diagnostic test for an array of Mycobacterial diseases in production animals. Today they are focused on Tuberculosis and paratuberculosis (MAP) and their test- Further, with the support of NIH, PBD is embarking on an additional trail to test humans for TB using the same phage based methodology and we are anticipating NIH grants in the second half of 2020. Altorum Fund/Altorum Foundation (2021 - 2022) Working with Altorum Fund and Foundation for investment in emerging Bio firms and Clean Energy. Identify and support the emergence of new and high impact applications.